We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+5.17%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$22B
AUM Growth
-$1.91B
Cap. Flow
-$2.72B
Cap. Flow %
-12.33%
Top 10 Hldgs %
10.77%
Holding
2,414
New
528
Increased
533
Reduced
664
Closed
678

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$229M
2
AA icon
Alcoa
AA
+$206M
3
V icon
Visa
V
+$130M
4
DRI icon
Darden Restaurants
DRI
+$127M
5
NTRS icon
Northern Trust
NTRS
+$127M

Sector Composition

Rank Sector Weight
1 Financials 17.13%
2 Consumer Discretionary 13.37%
3 Technology 9.27%
4 Industrials 7.54%
5 Real Estate 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LL
2226
DELISTED
LL Flooring Holdings, Inc.
LL
-66,585
Closed -$1.52M
OSG
2227
DELISTED
Overseas Shipholding Group Inc.
OSG
-26,967
Closed -$77K
NWLI
2228
DELISTED
National Western Life Group, Inc. Class A
NWLI
-900
Closed -$274K
WRK
2229
DELISTED
WestRock Company
WRK
-13,972
Closed -$897K
SIX
2230
DELISTED
Six Flags Entertainment Corp.
SIX
-48,126
Closed -$3M
DCPH
2231
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-10,000
Closed -$200K
AVGR
2232
DELISTED
Avinger, Inc. Common Stock
AVGR
-9
Closed -$35K
SP
2233
DELISTED
SP Plus Corporation
SP
-7,434
Closed -$265K
NBSE
2234
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-61
Closed -$5K
MDC
2235
DELISTED
M.D.C. Holdings, Inc.
MDC
-333,386
Closed -$7.98M
EXPR
2236
DELISTED
Express, Inc.
EXPR
-6,806
Closed -$975K
NSTG
2237
DELISTED
NanoString Technologies, Inc.
NSTG
-22,546
Closed -$169K
IMGN
2238
DELISTED
Immunogen Inc
IMGN
-68,023
Closed -$716K
IMGN
2239
PUT
DELISTED
Immunogen Inc
IMGN
-1,250,000
Closed -$13.2M
ARAV
2240
DELISTED
Aravive, Inc. Common Stock
ARAV
-9,524
Closed -$94K
RPT
2241
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-35,175
Closed -$435K
TRTN
2242
DELISTED
Triton International Limited
TRTN
-26,565
Closed -$813K
VRAY
2243
DELISTED
ViewRay, Inc.
VRAY
-327,500
Closed -$2.11M
ACOR
2244
DELISTED
Acorda Therapeutics
ACOR
-106
Closed -$300K
BLCM
2245
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-2,008
Closed -$132K
AQUA
2246
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-831,759
Closed -$17.7M
SIOX
2247
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-20,811
Closed -$221K
CNCE
2248
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-11,995
Closed -$275K
UMPQ
2249
DELISTED
Umpqua Holdings Corp
UMPQ
-1,173,409
Closed -$25.1M
LHCG
2250
DELISTED
LHC Group LLC
LHCG
-93,422
Closed -$5.75M

Similar funds

Balyasny Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Balyasny Asset Management held 2,414 positions worth $22B, down 8% from $23.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management withdrew a net $2.72B in Q2 2018, closing 678 positions and reducing 664 holdings. Its most notable exit was Burlington, an estimated $114M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Balyasny Asset Management opened a new position in Evergy worth $156M.

  • Balyasny Asset Management's largest Q2 2018 buy was Evergy: 2,779,050 shares worth $156M.
  • Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $366M increase.
  • Balyasny Asset Management's biggest Q2 2018 reduction was Walt Disney, cutting an estimated $229M.
  • Balyasny Asset Management fully exited Burlington in Q2 2018, selling an estimated $114M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $22B portfolio in Q2 2018.
  • Balyasny Asset Management opened 528 new positions and closed 678 in Q2 2018.
  • Balyasny Asset Management's portfolio value fell 8% quarter-over-quarter to $22B.

Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.